The company belongs to the pharmaceutical industry's investment management enterprise, the pharmaceutical industry specific business areas, mainly in its holding, shares of the company started. The company mainly engaged in pharmaceutical distribution business, including, manufacture and sale of medical equipment, pharmaceutical manufacturing business three categories. Holding shares in the company of the companies that have a direct relationship between the pharmaceutical distribution business. Company owned 10 subsidiaries, mainly in the pharmaceutical distribution business Sinopharm, Medicines and Chinese pharmaceutical company. Among them, two Sinopharm and Medicines Company's business includes pharmaceutical net sales, drug allocation, three retail drugs. In addition, the company in the field of narcotics distribution monopoly is its most prominent feature. In addition to narcotic drugs and other specialty pharmaceuticals, the company's distribution and agents to import, joint venture based drugs. Domestic production base in the three anesthetics, the company has two shares: 47.1% stake in Qinghai Pharmaceutical Group and Yichang Humanwell Pharmaceutical 20 percent.
Basic Information
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
54.72%
Purchase this report to view the information.
1.31%
Purchase this report to view the information.
0.97%
Purchase this report to view the information.
0.58%
Purchase this report to view the information.
0.54%
Subsidiaries
Sinopharm Airport (Beijing) International Trade Co., Ltd.
100%
Sinopharm Beijing Co., Ltd.
100%
Sinopharm Beijing Kangchen Biopharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after China National Medicines Corporation Ltd. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-2.09%▼
Total operating revenue
-2.06%▼
Operating profit (EBIT)
10.12%▲
Net Profit (Loss) for the Period
10.38%▲
Operating Profit Margin (ROS)
0.65%▲
Return on Equity (ROE)
-0.01%▼
Debt to Equity Ratio
-1.4%▼